title: Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole.
abstract: We tested the hypothesis that intracellular Ca++ [( Ca++]i) overload underlies the diastolic dysfunction of patients with hypertrophic cardiomyopathy. Myocardial tissue was obtained at the time of surgery or transplantation from patients with hypertrophic cardiomyopathy and was compared with control myocardium obtained from patients without heart disease. The isometric contractions and electrophysiologic properties of all myocardial specimens were recorded by standard techniques and [Ca++]i was measured with the bioluminescent calcium indicator aequorin. In contrast to the controls, action potentials, Ca++ transients, and isometric contraction and relaxation were markedly prolonged in the hypertrophic myocardium, and the Ca++ transients consisted of two distinct components. At 38 degrees C and 1 Hz pacing frequency, a state of relative Ca++ overload appeared develop, which produced a rise in end-diastolic [Ca++]i, incomplete relaxation, and fusion of twitches with a resultant decrease in active tension development. We also found that drugs with increase [Ca++]i, such as digitalis, exacerbated these abnormalities, whereas drugs that lower [Ca++]i, such as verapamil, or agents that increase cyclic AMP, such as forskolin, prevented them. These results may explain why patients with hypertrophic cardiomyopathy tolerate tachycardia poorly, and may have important implications with regard to the pharmacologic treatment of patients with hypertrophic cardiomyopathy.
authors.affiliation: Charles A. Dana Research Institute, Beth Isreal Hospital, Boston, MA.
authors.forename: J K
authors.initials: JK
authors.lastname: Gwathmey
authors.forename: S E
authors.initials: SE
authors.lastname: Warren
authors.forename: G M
authors.initials: GM
authors.lastname: Briggs
authors.forename: L
authors.initials: L
authors.lastname: Copelas
authors.forename: M D
authors.initials: MD
authors.lastname: Feldman
authors.forename: P J
authors.initials: PJ
authors.lastname: Phillips
authors.forename: M
authors.initials: M
authors.lastname: Callahan
authors.forename: F J
authors.initials: FJ
authors.lastname: Schoen
authors.forename: W
authors.initials: W
authors.lastname: Grossman
authors.forename: J P
authors.initials: JP
authors.lastname: Morgan
mesh_terms: D000328:Adult; D000368:Aged; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000502:physiology; D002312:Cardiomyopathy, Hypertrophic / Q000503:physiopathology*; D005576:Colforsin / Q000494:pharmacology; D003971:Diastole; D005260:Female; D006439:Hemodynamics; D006801:Humans; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D013327:Strophanthidin / Q000031:analogs & derivatives / Q000494:pharmacology; D013599:Systole; D014700:Verapamil / Q000494:pharmacology
chemical_list: D005576:Colforsin; D002110:Caffeine; D013327:Strophanthidin; D014700:Verapamil; C004681:acetylstrophanthidin; D007545:Isoproterenol; D002118:Calcium